Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Early research (Phase 1)Study completedNCT03860896
What this trial is testing

GB004 in Adult Subjects With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT05660109
What this trial is testing

Assess the Safety of TPM502 in Adults With Celiac Disease

Who this might be right for
Celiac Disease
Topas Therapeutics GmbH 28
Early research (Phase 1)Study completedNCT01380704
What this trial is testing

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AbbVie 51
Early research (Phase 1)Study completedNCT02195167
What this trial is testing

Dasotraline SEP360-105 Pediatric PK/PD Study

Who this might be right for
Pediatric Attention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 105
Early research (Phase 1)Looking for participantsNCT07280936
What this trial is testing

SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

Who this might be right for
ObesityOverweight
Beijing Suncadia Pharmaceuticals Co., Ltd 124
Testing effectiveness (Phase 2)Study completedNCT02519036
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease

Who this might be right for
Huntington's Disease
Ionis Pharmaceuticals, Inc. 46
Early research (Phase 1)Study completedNCT04701216
What this trial is testing

A Trial of SHR8735 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Atridia Pty Ltd. 48
Early research (Phase 1)Study completedNCT05017116
What this trial is testing

A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Chronic Hepatitis B
Suzhou Ribo Life Science Co. Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06857955
What this trial is testing

Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Who this might be right for
Hypertension
Novartis Pharmaceuticals 396
Early research (Phase 1)Study completedNCT05760300
What this trial is testing

A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

Who this might be right for
Chronic Hepatitis D Infection
Gilead Sciences 41
Early research (Phase 1)Study completedNCT02064907
What this trial is testing

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

Who this might be right for
Bioavailability
Takeda 52
Early research (Phase 1)UnknownNCT04221399
What this trial is testing

Type 2 Diabetes Patients With Renal Impairment

Who this might be right for
Type2 Diabetes
Daewoong Pharmaceutical Co. LTD. 35
Testing effectiveness (Phase 2)WithdrawnNCT00482287
What this trial is testing

Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients

Who this might be right for
HypotensionCardiopulmonary Bypass
Meditor Pharmaceuticals Ltd.
Early research (Phase 1)Study completedNCT00792493
What this trial is testing

Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

Who this might be right for
Healthy
Orion Corporation, Orion Pharma 51
Early research (Phase 1)Looking for participantsNCT06857214
What this trial is testing

GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Sichuan Baili Pharmaceutical Co., Ltd. 84
Early research (Phase 1)Study completedNCT02766647
What this trial is testing

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Who this might be right for
Neutropenia (Low White Blood Cell Count)
Pfizer 24
Early research (Phase 1)Study completedNCT01715909
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Who this might be right for
Influenza
Hoffmann-La Roche 20
Early research (Phase 1)Study completedNCT02572349
What this trial is testing

Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

Who this might be right for
Healthy
Cyclerion Therapeutics 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation